NCT04647513

Brief Summary

The function of injectable fillers for the treatment of dermal contour deformities is to smooth dermal depressions formed by the loss of volume and the aging process. These fillers (also known as soft tissue augmentation medical devices) can correct the skin depressions/wrinkles, balance the disproportions or correct topographical anomalies. In this context, it is proposed to carry out in post-CE marking, an open, prospective and non-comparative study in order to document an adequate aesthetic correction of the most frequent areas treated with Art Filler Fine Lines, Art Filler Universal and Art Filler Lips as well as their immediate and long-term tolerance.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
232

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 12, 2019

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 4, 2019

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

November 23, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 1, 2020

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 21, 2021

Completed
Last Updated

March 8, 2022

Status Verified

March 1, 2022

Enrollment Period

3 months

First QC Date

November 23, 2020

Last Update Submit

March 7, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Correction on D21 assessed with the global clinical aesthetic score

    Objectively measure the improvement according to a global Aesthetic clinical scoring from D0 to D21 of * after injection of Art Filler Fine lines * forehead wrinkles (at least 30 subjects) * upper lip wrinkles (at least 30 subjects) * cheek folds (at least 30 subjects) * crow's feet wrinkles (30 subjects) * after injection of Art Filler Universal * lips volume (at least 30 subjects) * nasolabial folds alone or with marionette wrinkles (at least 30 subjects) * after injection of Art Filler Lips * lips volume (at least 30 subjects) * Very deep nasolabial folds alone or with marionette wrinkles (at least 30 subjects)

    D21 (21 days after the injections)

Study Arms (8)

Art Filler Fine Lines (forehead)

EXPERIMENTAL

Injection of Art Filler Fine Lines in Forehead wrinkles

Device: Intradermal injection (superficial dermis for Art Filler Fine Lines / moderately deep to deep dermis for Art Filler Universal and Art Filler Lips)

Art Filler Fine Lines (upper lip)

EXPERIMENTAL

Injection of Art Filler Fine Lines in upper lip wrinkles

Device: Intradermal injection (superficial dermis for Art Filler Fine Lines / moderately deep to deep dermis for Art Filler Universal and Art Filler Lips)

Art Filler Fine Lines (cheek folds)

EXPERIMENTAL

Injection of Art Filler Fine Lines in cheek folds

Device: Intradermal injection (superficial dermis for Art Filler Fine Lines / moderately deep to deep dermis for Art Filler Universal and Art Filler Lips)

Art Filler Fine Lines (crow's feet)

EXPERIMENTAL

Injection of Art Filler Fine Lines in crow's feet

Device: Intradermal injection (superficial dermis for Art Filler Fine Lines / moderately deep to deep dermis for Art Filler Universal and Art Filler Lips)

Art Filler Universal (lips volume)

EXPERIMENTAL

Injection of Art Filler Universal in lips

Device: Intradermal injection (superficial dermis for Art Filler Fine Lines / moderately deep to deep dermis for Art Filler Universal and Art Filler Lips)

Art Filler Universal (nasolabial folds)

EXPERIMENTAL

Injection of Art Filler Universal in nasolabial folds

Device: Intradermal injection (superficial dermis for Art Filler Fine Lines / moderately deep to deep dermis for Art Filler Universal and Art Filler Lips)

Art Filler Lips (lips volume)

EXPERIMENTAL

Injection of Art Filler Lips in lips

Device: Intradermal injection (superficial dermis for Art Filler Fine Lines / moderately deep to deep dermis for Art Filler Universal and Art Filler Lips)

Art Filler Lips (very deep nasolabial folds)

EXPERIMENTAL

Injection of Art Filler Lips in very deep nasolabial folds

Device: Intradermal injection (superficial dermis for Art Filler Fine Lines / moderately deep to deep dermis for Art Filler Universal and Art Filler Lips)

Interventions

The function of injectable fillers for the treatment of dermal contour deformities is to smooth dermal depressions formed by the loss of volume and the aging process. These fillers (also known as soft tissue augmentation medical devices) can correct the skin depressions/wrinkles, balance the disproportions or correct topographical anomalies.

Art Filler Fine Lines (cheek folds)Art Filler Fine Lines (crow's feet)Art Filler Fine Lines (forehead)Art Filler Fine Lines (upper lip)Art Filler Lips (lips volume)Art Filler Lips (very deep nasolabial folds)Art Filler Universal (lips volume)Art Filler Universal (nasolabial folds)

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects who had signed a written informed consent
  • Man or Woman aged ≥ 19 years old
  • Subject having a Fitzpatrick Phototype I to IV
  • Subject having a score of ≥ 1 in the Global aesthetic scale scoring system on at least one area of interest (forehead wrinkles, upper lip wrinkles, cheek folds, crow's feet wrinkles, nasolabial folds and/or marionette wrinkles) and/or ≤ 2 for the lip volume
  • Subject having at least one of the following scales by clinical scoring
  • For subjects injected by Art Filler Fine Lines:
  • a grade ≥ 3 and ≤ 6 on the upper lip wrinkles scale from Bazin
  • a grade ≥ 3 and ≤ 5 on the cheek folds scale from Bazin
  • For women :
  • a grade ≥ 2 and ≤ 5 on the forehead wrinkles scale from Bazin
  • a grade ≥ 2 and ≤ 6 on the crow's feet wrinkles scale from Bazin
  • For men :
  • a grade ≥ 2 and ≤ 6 on the forehead wrinkles from Bazin
  • a grade ≥ 2 and ≤ 6 on the crow's feet wrinkles from Bazin
  • For subjects injected by Art Filler Universal:
  • +9 more criteria

You may not qualify if:

  • Subject deprived of freedom by an administrative or legal decision
  • Subject who has received indemnification of 4500 € during the 12 previous months for his/her participation in clinical trials (including participation in this study).
  • Subject who had facial injections/implants of any non-absorbable fillers in her/his whole life.
  • Subject who had laser sessions for skin rejuvenation or laser resurfacing during the 12 previous months or a surgical facelift during the 2 years before the study.
  • Subject with a history of facial aesthetic injection (hyaluronic acid within the previous year, botulinum toxin within the last 6 months and long-term temporary injectable implants (semi-permanent implants) within the previous 2 years).
  • Subject with a skin-retaining device on the face (mesh, gold wire, liquid silicone or other particulate material).
  • Subject who underwent a non-invasive rejuvenation method such as moderate to deep peeling, ultrasound, radiofrequency devices or lasers within the last 6 months.
  • Subject with a history of severe multiple allergies or anaphylactic shock.
  • Subject with a known hypersensitivity to hyaluronic acid, Lidocaine and/or other components of Art Filler Fine Lines®, Art Filler Universal® and Art Filler Fine Lips® solutions.
  • Subject with a known hypersensitivity to chlorhexidine.
  • Subject with a known hypersensitivity to lidocaine or local amide anesthetics.
  • Subject tending to develop inflammatory skin diseases or hypertrophic scars.
  • Subject with a history of streptococcal disease (recurring angina, rheumatic fever).
  • Subject with oral or injectable corticoid treatment (or not stopped for at least 3 months). Inhaled corticoids are permitted as well as topical corticotherapy not involving the head or the neck.
  • Subjects with any concomitant treatment (or not stopped for at least a year) by immunosuppressant or chemotherapy.
  • +8 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dr Mihai Gorj

Paris, 75116, France

Location

MeSH Terms

Interventions

Injections, Intradermal

Intervention Hierarchy (Ancestors)

Injections, SubcutaneousInjectionsDrug Administration RoutesDrug TherapyTherapeutics

Study Officials

  • Ferial Fanian, MD

    Laboratoires FILLMED

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Intradermal injection (superficial dermis for Art Filler Fine Lines / moderately deep to deep dermis for Art Filler Universal and Art Filler Lips). To this end, subjects in whom a correction of at least one of the studied zones is sought, will be included. The aesthetic correction will be appreciated at 3 weeks. Subjects will be followed over 18 months. The persistence of the correction will be evaluated at 3, 6, 9, 12, 15 and 18 months. Around 200 subjects aged more than 19 years old with following distribution: * Art Filler Fine Lines * Forehead wrinkles * Upper lip wrinkles * Cheek folds * Crow's feet wrinkles * Art Filler Universal * Volume of the lips (for soft volumizing effect) * Nasolabial folds alone or with marionette lines * Art Filler Lips * Volume of the lips (for plumped lips) * Very deep Nasolabial folds alone or with marionette lines
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 23, 2020

First Posted

December 1, 2020

Study Start

April 12, 2019

Primary Completion

July 4, 2019

Study Completion

December 21, 2021

Last Updated

March 8, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations